Navigation Links
USC and Coulter Foundation Partner to Invest $5M in Breakthrough Innovation in Biomedical Engineering
Date:4/26/2011

tend, and improve patient lives. The Foundation's broad mandate addresses suffering from any disease or condition, in any size market, in any discipline, in any country around the world.

"This award is a testament to the national leadership of our Biomedical Engineering Department in Translational Biomedical Engineering Research," said Yannis C. Yortsos, Dean of the USC Viterbi School of Engineering. "The Program will contribute to solving pressing societal health issues. It also fits well with the strategic plan of our BME Department, the Viterbi School of Engineering and complements the University's vision to support interdisciplinary and translational research."

Dr. Norberto Grzywacz, Professor and Chair of the Viterbi School's Department of BME led the collaborative effort as its principal investigator (PI).  The co-PIs were Thomas A. Buchanan, M.D., Professor of Medicine, Obstetrics and Gynecology, Associate Dean of Clinical Research at the Keck School of Medicine, and Director of the CTSI, and Krisztina "Z" Holly, Vice Provost for Innovation and Executive Director of the USC Stevens Institute for Innovation. The team also included Dr. Richard Hull, Senior Director for New Ventures and Alliances at the USC Stevens Institute for Innovation.

"This program harnesses critical gap funding, expertise, and focus to move USC's breakthrough biomedical engineering ideas into positive societal impact," said Holly. "We are thrilled to be working with the Coulter Foundation; this partnership is a key new piece of our interdisciplinary approach to innovation here at USC."

Co-PI Buchanan adds, "This is an outstanding opportunity to create the new interdisciplinary research teams to develop new approaches to diagnose and treat human disease. CTSI was designed to do just that. We are both proud and excited to be part of the USC partnership that won this prestigious award."

The first co-Directors of the Program are Mr. Juan Felipe Va
'/>"/>

SOURCE USC Stevens Institute for Innovation; USC Viterbi School of Engineering
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Beckman Coulter to Present at the Thomas Weisel Healthcare Conference 2008
2. Beckman Coulter to Present at the Morgan Stanley Healthcare Unplugged Conference
3. Beckman Coulter Investor Events Second Half of 2008
4. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
5. Beckman Coulter to Present at the Oppenheimer Annual Healthcare Conference
6. Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care
7. Beckman Coulter to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
8. Beckman Coulter to Present at Upcoming Healthcare Conferences
9. Beckman Coulter to Host Annual Business Review
10. Beckman Coulter to Present at the 27th Annual J.P. Morgan Healthcare Conference
11. Beckman Coulter Announces Fourth Quarter 2008 Earnings to be Released on Monday, February 9, 2009, After Market Closes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)...  Transwestern | RBJ today announces the firm brokered a long-term ... a leading biopharmaceutical company, at Two Ledgemont Center in ... Richards , president, and Brian Cohen , senior vice ... building at 95 Hayden Ave. Photo - ...
(Date:1/22/2015)... 22, 2015 Protocol Networks brings independent ... team of brand-neutral, independent consultants, Protocol Networks has recently ... that over the years, his company has attracted several ... of Plainfield, as well as others. With the success ...
(Date:1/22/2015)... January 22, 2015 Controlled Substance Compliance ... which helps companies check the legal requirements around using ... to China. , As their international operations expand ... adopting software solutions built as a result of the ...
(Date:1/22/2015)... PALO ALTO, Calif. , Jan. 22. 2015  Varian Medical ... equipment and software, has been honored for its commitment to ... most sustainable companies. Varian is the highest ranked healthcare equipment ... ranking, announced today during the World Economic Forum at ...
Breaking Biology Technology:Transwestern | RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Protocol Networks Brings Independent Technology Consulting to the Constitution State 2Global Compliance Service for Controlled Substances to Expand to China 2Varian Honored Among World's 100 Most Sustainable Corporations 2
... The shortlist of contenders for the highest ... narrowed tonight as the winners of the Siemens ... Finals were announced.  Cancer stem cell research earned ... Angela Zhang of Cupertino, California.  Research on molecular ...
... working at Argonne National Laboratory,s (ANL) Center for Nanoscale ... into nanowires, boosting the material,s functionality and providing potential ... led by Anirudha Sumant, a materials scientist at ANL, ... & Exhibition, held Oct. 30 Nov. 4, 2011, ...
... Corporation (OTCQX:RXPC) (OTCPK:RXPC), a developer and marketer of ... that all six proxy resolutions passed at a special ... statement was filed with the Securities and Exchange Commission ... and on the Company,s web site:   www.radient-pharma.com ...
Cached Biology Technology:Biochemistry and Bioengineering Research Brings California Students Closer to Nation's Highest Science Honor for High School Students 2Biochemistry and Bioengineering Research Brings California Students Closer to Nation's Highest Science Honor for High School Students 3Biochemistry and Bioengineering Research Brings California Students Closer to Nation's Highest Science Honor for High School Students 4Biochemistry and Bioengineering Research Brings California Students Closer to Nation's Highest Science Honor for High School Students 5Scientists carve nanowires out of ultrananocrystalline diamond thin films 2Radient Pharmaceuticals Announces Proxy Resolutions Approved at Special Meeting of Stockholders 2
(Date:12/11/2014)...  That blood pressure plays a role in human health has ... term for high blood pressure – was first described as ... that,s used in measuring blood pressure was invented in 1896. ... hypertension, its triggers and its effects. In fact, recent findings ...
(Date:12/10/2014)... a leader in performance biometric data sensor technology, today ... licensees for highly accurate, clinically validated biometric technology. This ... fitness and health sectors, but first responders/military and gaming ... as useful as the biometric data it delivers. As ...
(Date:12/10/2014)... Markets ( http://www.researchandmarkets.com/research/xclcvw/biometrics_market ) has announced the ... report to their offering. ... and smart cards for projects such as rural banking ... the major trends witnessed in the market. Besides the ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wearable Technology Products Demand Highly Accurate Biometric Technology 2Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2
... Tumor metastasis, the ability of cancer cells to migrate from ... accounts for over 90% of cancer deaths. When patients die ... by malignant cells that split off from the primary cancer ... the Ludwig Center at the University of Chicago hypothesized over ...
... School of Medicine and AstraZeneca, a global biopharmaceutical company, ... 2a trial to assess the effectiveness of AZD5847, a ... patients with HIV co-infection. The study is sponsored ... (NIAID), part of the U.S. National Institutes of Health. ...
... 2002-2003 was short-lived, but a novel type of human coronavirus ... humans and bats alike, a fact that could make the ... to be published in in mBio , the online ... 11. The new coronavirus, called hCoV-EMC, is blamed for five ...
Cached Biology News:Predictors of cancer disease progression improve patient selection for metastasis-directed therapy 2New tuberculosis drug trial begins in South Africa 2New coronavirus has many potential hosts, could pass from animals to humans repeatedly 2New coronavirus has many potential hosts, could pass from animals to humans repeatedly 3
Activating Agents, 7-azabenzotriazol-1-yloxy-tris-(pyrrolidino)phosphonium hexafluorophosphate...
The E. coli Expression System with Gateway Technology is designed to create E. coli expression clones containing the T7 promoter. The expression clones are ready for transformation and expression in ...
For use with SSP products or any application requiring agarose gel separation • Multiple formats available to meet various throughput needs • Includes replacement parts for each un...
Request Info...
Biology Products: